Latest News

This Week in Managed Care: May 26, 2017
This week, the top managed care news included the Congressional Budget Office's new score for the American Health Care Act; the White House released its fiscal year 2018 budget; and a cancer drug approval that is a first for the FDA.
Based on the results of the phase 2 ZUMA-1 trial in patients with refractory non-Hodgkin lymphoma, Kite Pharma has submitted for, and received, a priority review for its chimeric antigen receptor (CAR)-T cell treatment, axicabtagene ciloleucel.
A new study published in Diabetes Care investigates ways to prevent driving accidents among patients with type 1 diabetes, who may be at higher risk of having such mishaps.
Few people have adequate savings for long-term care, and most assume they will care for relatives and rely on family for their own care. A survey from the Associated Press and the NORC Center for Public Affairs Research found support for family leave policies across members of both parties.
A panel discussion on biosimilars at the ISPOR 22nd Annual International Meeting compared the progress in the United States with Europe, which has had a 10-year head start on the market.
Coverage of our peer-reviewed research in the healthcare and mainstream press.
Lee Barrett Explains How Abundance of Health Data Increases Risk of Breaches
As the amount of healthcare data and information exchange continues to grow, so does the threat of data breaches and cyberattacks, according to Lee Barrett, executive director of the Electronic Healthcare Network Accreditation Commission.
Ross Owen Highlights New Challenges of Adding Care for Families and Children
As Hennepin Health expands its focus from the Medicaid expansion population of single adults to families and children, it will need to shift the way it views return on investment since there can be large upfront costs with returns happening years later with this new population, explained Ross Owen, health strategy director of Hennepin County.
The Government Accountability Office has issued a report evaluating the continued public health response to the Zika virus in the US and detailing the remaining challenges and possible solutions.
Amy J. Reed, MD, died 4 years following her surgery that used a power morcellator to remove her uterus, resulting in the spread of a hidden cancer.
Impact of Money on Care: Dr Patricia Salber Interviews Dr Veena Shankaran
Earlier this year, Veena Shankaran, MD, MS, associate professor at the University of Washington, had a winning case study for the PAN Foundation's annual PAN Challenge. The case study outlined an education program created to improve patient financial literacy and help connect patients to funding organizations.
The American Medical Association declared obesity a disease in 2013, but insurers have been slow to cover drugs to treat the disease.

From the Journals

Enrollees in Medicaid plans employing prior authorization policies for opioid medications may have lower rates of opioid medication abuse and overdose.
This study investigates the impact of state prescription drug monitoring programs on drug overdose mortality rates for all drug categories.
The healthcare burden of opioid abuse is substantial; abusers often have complex healthcare needs and may require care beyond that which is required to treat abuse.
Across many measures of Veterans Health Administration mental health care program characteristics, treatment continuity is most strongly and positively associated with patient satisfaction.  
This study utilizes a validated instrument to create case and control groups to measure the effect of the Veterans Health Administration (VHA)’s patient-centered medical home (PCMH) model on utilization patterns among veterans with posttraumatic stress disorder (PTSD).
This study highlights disparities in care for diabetes and hypertension for individuals with serious mental illness compared with the general Medicaid and Medicare populations.
An interview with Daryl Pritchard, PhD, vice president for Science Policy at the Personalized Medicine Coalition, on the FDA's drug approval process, developments in the personalized medicine field, and reimbursement models that integrate diagnostics.
This study identified populations with non-cancer chronic pain to determine which patients may be more likely to receive an opioid prescription in an outpatient setting.
An overview of the FDA's Oncology Center of Excellence—a collaborative approach to the clinical approval process.
Compendia
COPD Compendium
Diabetes Compendium
GI Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Know Your News
HF Compendium
Formulary
Upcoming Partner Events
June 15-16, 2017
Philadelphia, PA
August 16-17, 2017
Philadelphia, PA
October 24-25, 2017
San Francisco, CA
Managed Care Cast
Managed Care Cast

Most Popular

AJMC Strategic Alliance

$vacMongoViewPlus$